Project information
Evaluation of dentritic cells administration in multiple myeloma.

Project Identification
NC6152
Project Period
1/2000 - 1/2002
Investor / Pogramme / Project type
Ministry of Health of the CR
MU Faculty or unit
Faculty of Medicine

Due to the short event-free survival and poor prognosis of patients in relapsing MM despite the use of myeloablative therapy we will try to improve their prognosis by using administration of dendritic cells primed with specific antigen. Idiotypic protein or peptides from myeloma cells lysate will be used as tumor associated antigens.

Publications

Total number of publications: 2


You are running an old browser version. We recommend updating your browser to its latest version.

More info